Evaluating the Use of Large-dose, Extended Interval Vancomycin Intravenous Administration for Skin and Soft Tissue Infections

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions

Skin and Soft Tissue Infections

Interventions

DRUG

vancomycin

vancomycin 30 mg/kg intravenous administered once daily

DRUG

vancomycin

vancomycin 15 mg/kg intravenous administered twice daily (standard dosing)

Trial Locations (1)

Royal Columbian Hospital, New Westminster